Cargando…
Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
BACKGROUND: Energy metabolism disorder is a critical process in lung ischemia–reperfusion injury (LIRI). This study was aimed to determine the effects of resolvin D1 (RvD1) on the energy metabolism in LIRI. METHODS: Forty Sprague–Dawley rats were divided into the following groups: Sham group; untrea...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806414/ https://www.ncbi.nlm.nih.gov/pubmed/27009328 http://dx.doi.org/10.1186/s12967-016-0835-7 |
_version_ | 1782423232060588032 |
---|---|
author | Zhao, Qifeng Wu, Ji Hua, Qingwang Lin, Zhiyong Ye, Leping Zhang, Weixi Wu, Guowei Du, Jie Xia, Jie Chu, Maoping Hu, Xingti |
author_facet | Zhao, Qifeng Wu, Ji Hua, Qingwang Lin, Zhiyong Ye, Leping Zhang, Weixi Wu, Guowei Du, Jie Xia, Jie Chu, Maoping Hu, Xingti |
author_sort | Zhao, Qifeng |
collection | PubMed |
description | BACKGROUND: Energy metabolism disorder is a critical process in lung ischemia–reperfusion injury (LIRI). This study was aimed to determine the effects of resolvin D1 (RvD1) on the energy metabolism in LIRI. METHODS: Forty Sprague–Dawley rats were divided into the following groups: Sham group; untreated ischemia–reperfusion (IR) control; IR treated with normal saline (IR-NS); and IR treated with RvD1 (IR-RV) (100 μg/kg, iv). LIRI and energy metabolism disorder were determined in these rats. RESULTS: The results revealed that the levels of interleukin (IL)-1β, tumor necrosis factor-α, IL-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-2, cytokine-induced neutrophil chemoattractant-1, injured alveoli rate, apoptosis index, pulmonary permeability index, malondialdehyde, ADP, and lactic acid were increased, whereas the levels of ATP, ATP/ADP, glycogen, Na(+)–K(+)-ATPase, superoxide dismutase, glutathione peroxidase activity, pulmonary surfactant associated protein-A, and oxygenation index were decreased in rats with LIRI. Except for IL-10, all these biomarkers of LIRI and its related energy metabolism disorder were significantly inhibited by RvD1 treatment. In addition, histological analysis via hematoxylin–eosin staining, and transmission electron microscopy confirmed that IR-induced structure damages of lung tissues were reduced by RvD1. CONCLUSION: RvD1 improves the energy metabolism of LIRI disturbance, protects the mitochondrial structure and function, increases the ATP, glycogen content and Na(+)–K(+)-ATPase activity of lung tissue, balances the ratio of ATP/ADP and finally decreases the rate of apoptosis, resulting in the protection of IR-induced lung injury. The improved energy metabolism after LIRI may be related to the reduced inflammatory response, the balance of the oxidative/antioxidant and the pro-inflammatory/anti-inflammatory systems in rats. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0835-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4806414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48064142016-03-24 Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung Zhao, Qifeng Wu, Ji Hua, Qingwang Lin, Zhiyong Ye, Leping Zhang, Weixi Wu, Guowei Du, Jie Xia, Jie Chu, Maoping Hu, Xingti J Transl Med Research BACKGROUND: Energy metabolism disorder is a critical process in lung ischemia–reperfusion injury (LIRI). This study was aimed to determine the effects of resolvin D1 (RvD1) on the energy metabolism in LIRI. METHODS: Forty Sprague–Dawley rats were divided into the following groups: Sham group; untreated ischemia–reperfusion (IR) control; IR treated with normal saline (IR-NS); and IR treated with RvD1 (IR-RV) (100 μg/kg, iv). LIRI and energy metabolism disorder were determined in these rats. RESULTS: The results revealed that the levels of interleukin (IL)-1β, tumor necrosis factor-α, IL-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-2, cytokine-induced neutrophil chemoattractant-1, injured alveoli rate, apoptosis index, pulmonary permeability index, malondialdehyde, ADP, and lactic acid were increased, whereas the levels of ATP, ATP/ADP, glycogen, Na(+)–K(+)-ATPase, superoxide dismutase, glutathione peroxidase activity, pulmonary surfactant associated protein-A, and oxygenation index were decreased in rats with LIRI. Except for IL-10, all these biomarkers of LIRI and its related energy metabolism disorder were significantly inhibited by RvD1 treatment. In addition, histological analysis via hematoxylin–eosin staining, and transmission electron microscopy confirmed that IR-induced structure damages of lung tissues were reduced by RvD1. CONCLUSION: RvD1 improves the energy metabolism of LIRI disturbance, protects the mitochondrial structure and function, increases the ATP, glycogen content and Na(+)–K(+)-ATPase activity of lung tissue, balances the ratio of ATP/ADP and finally decreases the rate of apoptosis, resulting in the protection of IR-induced lung injury. The improved energy metabolism after LIRI may be related to the reduced inflammatory response, the balance of the oxidative/antioxidant and the pro-inflammatory/anti-inflammatory systems in rats. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0835-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-24 /pmc/articles/PMC4806414/ /pubmed/27009328 http://dx.doi.org/10.1186/s12967-016-0835-7 Text en © Zhao et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhao, Qifeng Wu, Ji Hua, Qingwang Lin, Zhiyong Ye, Leping Zhang, Weixi Wu, Guowei Du, Jie Xia, Jie Chu, Maoping Hu, Xingti Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung |
title | Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung |
title_full | Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung |
title_fullStr | Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung |
title_full_unstemmed | Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung |
title_short | Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung |
title_sort | resolvin d1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806414/ https://www.ncbi.nlm.nih.gov/pubmed/27009328 http://dx.doi.org/10.1186/s12967-016-0835-7 |
work_keys_str_mv | AT zhaoqifeng resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT wuji resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT huaqingwang resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT linzhiyong resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT yeleping resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT zhangweixi resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT wuguowei resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT dujie resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT xiajie resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT chumaoping resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung AT huxingti resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung |